All In MedTech

Device Trial Radar · NCT02492880

CoverEdge Algorithm Programming Study

Study to Characterize the Effects of Programming Features of the Boston Scientific Precision Spectra™ Spinal Cord Stimulator System Using the CoverEdge™ Surgical Leads

Last checked: Nov 20, 2026Latest source record: Nov 4, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

15

Actual

Start

Jul 20, 2015

Primary completion

Feb 21, 2017

Study completion Feb 21, 2017

Sponsor

Lead sponsor
Boston Scientific CorporationPublic (BSX)
Sponsor type
Industry
First posted
Jul 9, 2015

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Basic science
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a prospective, on-label, multi-center, non-randomized, exploratory, single-arm study to characterize the effects of programming features of the Boston Scientific Precision Spectra™ Spinal Cord Stimulator (SCS) System using the CoverEdge™ surgical lead.

Conditions

  • Chronic Pain

Interventions

  • Precision Spectra™ SCS system programming featuresDevice

    Precision Spectra™ SCS system programming features using the CoverEdge surgical lead.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Paresthesia Distribution From Subject Completed Paresthesia Drawing QuestionnaireTime frame: minimum 25 days post IPG implant

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Barolat Neuroscience

    Denver, Colorado

  • Albany Medical Center

    Albany, New York

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.